Peripheral Neuropathy Foot 2026: Nerve Pain | DPM

Peripheral Neuropathy in the Foot: Treatment by Symptom Type and Severity

Peripheral neuropathy affecting the feet presents in three distinct symptom patterns — each requiring a different treatment approach. Getting the symptom type right is the first step to effective management. Positive symptoms (burning, tingling, shooting pain) respond differently than negative symptoms (numbness, loss of protective sensation) or mixed presentations. The table below maps symptom type to evidence-based treatment options, which is how we approach neuropathy at our Michigan podiatry practice.

Symptom Type	Presentation	First-Line Treatment	Second-Line	Podiatric Management	Evidence Level
Positive / Painful Neuropathy (burning, tingling, shooting)	Burning, stabbing, electric shock sensations; worse at night; allodynia (light touch painful); pain present with numbness; classic “diabetic neuropathic pain”	Pregabalin (Lyrica) 75-300mg BID or Duloxetine (Cymbalta) 60-120mg/day — FDA-approved for diabetic peripheral neuropathy pain; equivalent efficacy; side effect profile guides choice	Gabapentin 300-1200mg TID; tricyclic antidepressants (nortriptyline); topical capsaicin 8% patch (Qutenza); TENS therapy (100-150 Hz, see TENS protocol); combination therapy	Custom orthotics with metatarsal pad offloading; total contact casting for severe allodynia; vibration therapy adjunct; regular protective footwear fitting; nail care (patients cannot feel ingrown toenails)	HIGH — multiple RCTs; FDA approval for pregabalin and duloxetine in DPN pain; NNT ~4 (one in four patients achieves 50%+ pain reduction)
Negative / Loss of Sensation (numbness, insensitivity)	Numbness, loss of vibration sense, absent monofilament response; Semmes-Weinstein monofilament >5.07 (10g) indicates loss of protective sensation (LOPS); foot ulcer risk begins here; no pain — dangerous because injuries go unnoticed	Glucose control optimization (A1C target <7%); blood pressure control; smoking cessation; B12 supplementation if deficient; address underlying cause (metabolic, toxic, nutritional)	Alpha-lipoic acid 600mg/day (moderate evidence for slowing progression); B-vitamin complex; methylcobalamin injections if severe B12 deficiency; referral to neurology for non-diabetic etiologies	Annual monofilament screening; therapeutic footwear (Medicare Part B diabetic shoes when LOPS documented); custom orthotics for pressure redistribution; daily foot inspection education; wound prevention protocol; nail care every 6-8 weeks	HIGH for glucose control (DCCT/UKPDS trials); MODERATE for nutritional supplementation; HIGH for protective footwear reducing ulcer incidence by 50-65%
Small Fiber Neuropathy (early, normal EMG)	Burning feet with normal nerve conduction studies; involves C-fibers and Aδ-fibers (EMG tests large fibers only); diagnosis requires skin punch biopsy (intraepidermal nerve fiber density) or corneal confocal microscopy; often missed	Same as painful neuropathy; skin biopsy via neurology referral to confirm; identify and treat underlying cause (metabolic syndrome, autoimmune, cryptogenic); avoid neurotoxic medications	IV immunoglobulin if autoimmune etiology confirmed; low-dose naltrexone (emerging evidence); mitochondrial supplement protocol if mitochondrial etiology suspected	Protective footwear from early stage (before LOPS develops); regular podiatry monitoring to detect when large fiber involvement begins; monofilament testing every 6 months to detect progression	MODERATE — growing evidence base for small fiber pathology as distinct entity; treatment extrapolated from painful neuropathy trials
Tarsal Tunnel Syndrome (compressive neuropathy — distinct from systemic neuropathy)	Tibial nerve compression at tarsal tunnel (medial ankle); burning/tingling sole and toes; positive Tinel’s sign at medial ankle; EMG may show tibial nerve delay; NOT systemic neuropathy — single nerve compression	Custom orthotics (reduces pronation and tarsal tunnel tension); night splinting; corticosteroid injection into tarsal tunnel; anti-inflammatory protocol; activity modification	Surgical decompression (tarsal tunnel release) when conservative treatment fails at 3-6 months; outcomes best when compression etiology identified (ganglion cyst, accessory muscle, enlarged vein)	Distinguish from systemic DPN clinically: TTS is unilateral in 70%, has positive Tinel’s, is worse with prolonged standing, improved by rest; DPN is bilateral, sock-and-glove distribution, worse at night	MODERATE — tarsal tunnel surgery improves symptoms in 75-80% when structural compression confirmed; poor outcomes when nerve is intrinsically diseased (cannot surgically fix DPN)

Diabetic Foot Neuropathy: Annual Monitoring Protocol and Risk Stratification

Risk Category	Clinical Features	Podiatry Visit Frequency	Screening Tests	Footwear Recommendation	Action Triggers
Low Risk (Category 0)	Diabetes + intact protective sensation (monofilament <5.07 passes); no PAD (ABI 0.9-1.3); no foot deformity; no prior ulcer	Annual podiatry visit; patient self-inspection daily; PCP foot exam each visit	10g monofilament (10 sites); vibration tuning fork (128 Hz); ABI if vascular symptoms; visual inspection for callus formation	Properly fitted supportive shoes; avoid barefoot walking; cushioned insoles; no prescription footwear required at this stage	Any loss of monofilament response → advance to Category 1; any new callus or deformity → podiatry sooner
Moderate Risk (Category 1)	LOPS (monofilament fails) OR PAD (ABI <0.9) but no deformity; no prior ulcer; one risk factor present	Every 3-6 months; more frequent if wound care needed	Monofilament each visit; vibration; ABI annually; Doppler if ABI borderline; plantar pressure mapping if available	Depth-inlay shoe (Medicare Part B diabetic shoes if LOPS documented); custom orthotics for pressure redistribution; avoid flip-flops/sandals; inspect shoes before wearing	Any skin breakdown → same-day podiatry; any new deformity (hammertoe, bunion progression) → earlier visit; A1C >9% → coordinate with endocrinology
High Risk (Category 2)	LOPS + PAD together; OR LOPS + deformity (hammertoe, Charcot deformity, prominent MT head); no prior ulcer	Every 2-3 months; nail care at each visit (cannot safely perform at home with LOPS)	Monofilament; ABI; toe pressure (TBI) if ABI >1.3 (calcified vessels); plantar pressure mapping; wound check each visit	Custom-molded diabetic shoes; custom foot orthotics (not OTC); total contact insole; rocker-bottom modification if rocker gait needed; regular shoe inspection for pressure points	Any skin breakdown → same-day wound care assessment; rest pain or tissue loss → urgent vascular surgery referral; Charcot suspicion → non-weight-bearing immediately, MRI
Very High Risk (Category 3)	Prior foot ulcer (healed); or prior amputation; LOPS + PAD + deformity; history of Charcot neuroarthropathy	Every 1-2 months; wound care as needed; nail care every 6-8 weeks	Full wound surveillance; Doppler each visit if PAD; wound measurement if any breakdown; HbA1c coordination with PCP/endocrinology	Fully custom diabetic footwear; off-loading devices as needed; may need AFO (ankle-foot orthosis) for Charcot foot; DH pressure relief walker for active wound healing	New ulcer → wound care protocol same day; wound not healing at 4 weeks → vascular assessment; any bone involvement → MRI and infectious disease; fever/leukocytosis with foot wound → ER for osteomyelitis workup

Quick Answer: Peripheral neuropathy affecting the feet causes numbness, burning, and tingling — most commonly from diabetes, vitamin B12 deficiency, or alcohol use. A podiatrist evaluates risk with monofilament testing and vibration threshold to prevent ulcers and amputation. Treatment includes glucose control, B12 supplementation, nerve pain medications, and protective footwear. Call (810) 206-1402.

Understanding Peripheral Neuropathy

Peripheral neuropathy is damage to the peripheral nervous system — the nerves that transmit sensation, motor signals, and autonomic function between the central nervous system and the body’s extremities. When the feet are affected, the condition disrupts the three nerve fiber types that protect them: sensory fibers (which detect pain, pressure, temperature, and vibration), motor fibers (which maintain intrinsic foot muscle tone and arch support), and autonomic fibers (which regulate sweat gland function and skin moisture).

The cumulative result of peripheral neuropathy in the feet is profound vulnerability: patients cannot feel that their shoes are rubbing a blister, that a foreign object is cutting their sole, that a pressure sore is forming over a bony prominence, or that an infection is spreading. This loss of protective sensation transforms minor injuries — which healthy people feel, adjust to, and heal — into the wounds, infections, and ultimately amputations that make diabetic neuropathy the leading cause of non-traumatic lower limb amputation in the United States.

Causes of Peripheral Neuropathy

Diabetes mellitus is by far the most common cause, affecting 50–70% of diabetic patients over their lifetime. Diabetic peripheral neuropathy (DPN) results from chronic hyperglycemia-induced nerve damage through multiple mechanisms: advanced glycation end products, oxidative stress, microvascular insufficiency, and direct sorbitol accumulation within nerve sheaths. DPN typically begins as a stocking-and-glove distribution affecting the toes first, progressing proximally over years.

Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 30–40% of patients receiving platinum-based (cisplatin, oxaliplatin) or taxane (paclitaxel, docetaxel) chemotherapy. CIPN may be dose-dependent and partially reversible, though complete resolution is not guaranteed. The foot care principles are identical to diabetic neuropathy during the period of sensory loss.

Hereditary neuropathies — particularly Charcot-Marie-Tooth (CMT) disease — cause progressive motor and sensory neuropathy beginning in childhood or early adulthood, producing characteristic foot deformities (high arch/pes cavus, hammer toes, intrinsic muscle atrophy) alongside sensory loss. CMT patients require specialized foot orthotics and often surgical foot reconstruction.

Other causes include: vitamin B12 deficiency (especially in patients taking metformin, which impairs B12 absorption); hypothyroidism; chronic alcohol use; HIV infection; MGUS (monoclonal gammopathy); and idiopathic neuropathy (30% of cases have no identifiable cause despite thorough evaluation).

Symptoms of Neuropathic Foot Problems

Peripheral neuropathy in the feet produces a characteristic symptom progression. Early stages involve positive symptoms: burning, aching, tingling (paresthesia), electric shooting pains, and hypersensitivity (allodynia) — even light touch to the foot causes discomfort. These symptoms are often worse at night, disrupting sleep. As the neuropathy progresses, negative symptoms emerge: numbness, loss of temperature sensation, loss of vibration sense, and ultimately loss of protective sensation — the ability to feel pain. Paradoxically, some patients report both painful burning and complete numbness simultaneously in different regions of the foot.

Motor involvement produces intrinsic foot muscle atrophy and weakness, causing gradual development of hammer toes, high arch (cavovarus), and forefoot prominence — these bony prominences become pressure points under the insensate forefoot, the most common location for diabetic ulcers.

Autonomic involvement reduces sweating, causing abnormally dry, cracked skin (anhidrosis) that is more susceptible to fissuring and infection entry. Patients often notice that their feet rarely sweat and have extremely dry skin.

Neuropathic Foot Evaluation at Balance Foot & Ankle

Dr. Biernacki performs a comprehensive neuropathic foot assessment at every diabetic and neuropathy-related visit:

Semmes-Weinstein 10-gram monofilament test: A standardized nylon filament is pressed against 10 sites on the plantar foot until it buckles (applying 10 grams of force). Inability to perceive the monofilament at any site indicates loss of protective sensation — the threshold associated with significantly elevated ulcer risk. This simple, evidence-validated test is the cornerstone of neuropathy surveillance.

Vibration perception testing with a 128 Hz tuning fork at the hallux — reduced or absent vibration sense is an early sensitive marker of neuropathy.

Ankle reflexes: absent Achilles tendon reflex is a sensitive clinical indicator of peripheral neuropathy.

Vascular assessment: palpation of dorsal pedis and posterior tibial pulses; ankle-brachial index (ABI) for patients with absent pulses or risk factors for peripheral artery disease. Coexisting PAD dramatically increases ulcer healing time and amputation risk.

Skin and nail assessment: callus distribution (identifying pressure points at risk for pre-ulcerative breakdown), nail condition (onychomycosis, thickening, deformity), skin dryness and fissuring, and inspection for early wounds or blisters between the toes and on the soles.

Preventive Foot Care for Neuropathic Patients

Therapeutic footwear prescription: Medicare’s Therapeutic Shoe Bill (TSB) program provides eligible diabetic patients with depth-inlay shoes and custom inserts annually. These shoes reduce plantar pressure at high-risk sites, protecting the insensate forefoot. Dr. Biernacki prescribes therapeutic footwear as a fundamental neuropathy prevention tool.

Custom orthotics with total-contact design: Distributing plantar pressure across the entire foot surface — rather than concentrating it at bony prominences — is the primary mechanical principle for preventing neuropathic ulcers. Custom total-contact insoles are fabricated from pressure-mapping or casting data to maximize surface contact area under the neuropathic forefoot.

Regular professional nail and callus care: Neuropathic patients should never attempt home nail trimming or callus management — the combination of poor sensation, poor eyesight (common in diabetics), and potential vascular compromise makes home nail care a significant wound risk. Professional nail trimming and callus debridement every 6–10 weeks prevents the pressure complications that home management risks.

Daily foot inspection and patient education: Using a handheld mirror or having a family member inspect plantar surfaces daily; never walking barefoot; reporting any redness, warmth, swelling, or skin break within 24 hours; keeping feet moisturized (not between toes); and wearing moisture-wicking socks are the daily habits that prevent the most common routes to serious complications.

Frequently Asked Questions

What is Neuropathy?

Neuropathy is a common foot/ankle condition that affects mobility and quality of life. Understanding the underlying cause is the first step in successful treatment. Our podiatrists at Balance Foot & Ankle perform a hands-on biomechanical exam, review your activity history, and use diagnostic imaging when appropriate to identify the root cause—not just treat the symptom. Many patients have been told to “rest and ice” without a deeper diagnostic workup; our approach is different.

Symptoms and warning signs

Common signs of neuropathy include pain that worsens with activity, morning stiffness, swelling, tenderness when palpated, and difficulty bearing weight. If you experience sudden severe pain, inability to walk, visible deformity, numbness or color change, contact our office the same day or visit urgent care—these can signal a more serious injury such as a fracture, tendon rupture, or vascular compromise. Diabetics with any foot wound should seek same-day care.

Conservative treatment options

Most cases of neuropathy respond to non-surgical care: structured rest, supportive footwear changes, custom orthotics, targeted stretching and strengthening protocols, anti-inflammatory medications when medically appropriate, and in-office procedures such as ultrasound-guided injections. We also offer advanced therapies including MLS laser therapy, EPAT/shockwave, regenerative injections, and image-guided procedures. Treatment is sequenced from least invasive to most invasive, and we explain the rationale at every step.

When is surgery considered?

Surgery is reserved for cases that fail 3-6 months of well-structured conservative care, when there is structural pathology (severe deformity, complete tear, advanced arthritis), or when imaging shows damage that will not heal without intervention. Our surgeons have performed 3,000+ foot and ankle procedures and prioritize minimally-invasive techniques whenever appropriate. We discuss recovery timelines, return-to-activity milestones, and realistic outcome expectations before any procedure is scheduled.

Recovery timeline and prevention

Recovery from neuropathy varies based on severity and chosen treatment path. Conservative cases often improve within 4-8 weeks with consistent adherence to the protocol. Post-procedural recovery may range from a few days (in-office procedures) to several months (reconstructive surgery). Long-term prevention involves footwear assessment, activity modification, structured strengthening, and regular check-ins with your podiatrist if you have a history of recurrence. We provide written home-exercise plans and digital follow-up support.

In-Office Treatment at Balance Foot & Ankle

If home treatment isn’t providing relief for your neuropathy, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.